InspireMD
NSPR
3 hedge funds and large institutions have $149K invested in InspireMD in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
171% more capital invested
Capital invested by funds: $55K → $149K (+$94K)
0.21% more ownership
Funds ownership: 0% → 0.21% (+0.21%)
25% less funds holding
Funds holding: 4 → 3 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$98.9K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$61.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$4K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$310 |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$1 |
NSPR Hedge Fund Activity: Q2 2019 in Review
3 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2019, worth a combined $149K — up 171% from $55K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NSPR and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $98.9K. The largest seller was UBS Group, exiting entirely with an estimated $10K sold.
- 3 institutional investors held InspireMD (NSPR) as of Q2 2019, down from 4 in Q1 2019.
- Funds reported $149K of InspireMD stock for Q2 2019, up 171% quarter-over-quarter.
- 2 funds opened new InspireMD positions in Q2 2019 and 3 closed out, a net change of -1 holder.
- The largest InspireMD buyer in Q2 2019 was Bank of New York Mellon, an estimated $98.9K added.
- The largest InspireMD seller in Q2 2019 was UBS Group, an estimated $10K sold.
Based on aggregated 13F filings for Q2 2019.